Matthew J. Barth

Matthew J. Barth

Hematology | Oncology

219 Bryant St
Buffalo, NY 14222

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

System-level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated With High One-year Survival and Reduced Cost.

System-level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated With High One-year Survival and Reduced Cost.

Journal: Transplantation and cellular therapy

Published: March 12, 2026

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Journal: Blood cancer journal

Published: October 26, 2025

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.

Journal: bioRxiv : the preprint server for biology

Published: August 13, 2025

Development of an adult neurofibromatosis clinic in the comprehensive cancer center setting and descriptive analysis of the first 100 patients with neurofibromatosis type 1.

Development of an adult neurofibromatosis clinic in the comprehensive cancer center setting and descriptive analysis of the first 100 patients with neurofibromatosis type 1.

Journal: Orphanet journal of rare diseases

Published: May 29, 2025

AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.

AMG176, an MCL-1 inhibitor, is active in pre-clinical models of aggressive B-cell lymphomas.

Journal: Leukemia & lymphoma

Published: April 19, 2023

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 09, 2022

Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.

Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.

Journal: Pediatric blood & cancer

Published: September 12, 2022

Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.

Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.

Journal: Blood cancer discovery

Published: August 08, 2022

An institutional review of genomic sequencing in pediatric solid tumors.

An institutional review of genomic sequencing in pediatric solid tumors.

Journal: Pediatric blood & cancer

Published: June 20, 2022

A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.

A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.

Journal: Blood advances

Published: August 25, 2021

Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.

Anaplastic lymphoma kinase inhibitor therapy in the treatment of inflammatory myofibroblastic tumors in pediatric patients: Case reports and literature review.

Journal: Journal of pediatric surgery

Published: December 07, 2020

Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell Lymphoma.

Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell Lymphoma.

Journal: EJHaem

Published: October 19, 2020

Showing 1-12 of 43

Last Updated: 09/26/2026